These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2219343)

  • 21. Cyclosporine A-induced acceptance of major histocompatibility complex-incompatible grafts differs immunologically from class I or minor antigen-mismatched grafts accepted in the absence of immunosuppression.
    Lim SM; White DJ; Calne RY
    Transplant Proc; 1987 Oct; 19(5):4252-3. PubMed ID: 3314024
    [No Abstract]   [Full Text] [Related]  

  • 22. Indirect T cell allorecognition and alloantibody-mediated rejection of MHC class I-disparate heart grafts.
    Pettigrew GJ; Lovegrove E; Bradley JA; Maclean J; Bolton EM
    J Immunol; 1998 Aug; 161(3):1292-8. PubMed ID: 9686590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An immunodominant minor histocompatibility alloantigen that initiates corneal allograft rejection.
    Haskova Z; Sproule TJ; Roopenian DC; Ksander AB
    Transplantation; 2003 Apr; 75(8):1368-74. PubMed ID: 12717232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of cytomegalovirus infection and acute rejection after allogeneic lung transplantation in the rat: virus-induced expression of major histocompatibility complex class II antigens.
    You XM; Steinmüller C; Wagner TO; Bruggeman CA; Haverich A; Steinhoff G
    J Heart Lung Transplant; 1996 Nov; 15(11):1108-19. PubMed ID: 8956120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transplantation of retinal pigment epithelial cells and immune response in the subretinal space.
    Zhang X; Bok D
    Invest Ophthalmol Vis Sci; 1998 May; 39(6):1021-7. PubMed ID: 9579482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolongation of heart allograft survival in course of donor specific antigen and alloserum treatment in the rat.
    Romaniuk A; Ryffa T; Rowiński W; Olszewski WL
    Arch Immunol Ther Exp (Warsz); 1989; 37(3-4):253-60. PubMed ID: 2639625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms in organ allograft rejection. An experimental and clinical study.
    Claesson K
    Scand J Urol Nephrol Suppl; 1987; 103():1-42. PubMed ID: 3321417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
    Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV
    Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence that the fate of class II-disparate corneal grafts is determined by the timing of class II expression.
    Ross J; Callanan D; Kunz H; Niederkorn J
    Transplantation; 1991 Feb; 51(2):532-6. PubMed ID: 1994550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice.
    Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T
    Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for processing of WAG antigens by the RT1-D class II MHC molecules of PVG rats during kidney allograft rejection.
    Priestley CA; Spencer SS; Sawyer GJ; Fabre JW
    Transplant Proc; 1990 Aug; 22(4):1947-8. PubMed ID: 2389491
    [No Abstract]   [Full Text] [Related]  

  • 32. Class II antigen expression on vascular endothelium of the graft in rat heart transplantation.
    Bouwman E; IJzermans JN; Heineman E; de Bruin RW; Marquet RL; Jeekel J
    Transplant Proc; 1987 Feb; 19(1 Pt 1):198-9. PubMed ID: 3152687
    [No Abstract]   [Full Text] [Related]  

  • 33. Infiltration pattern of rat heart allografts during rejection.
    Westra AL; Romaniuk A; Ryffa T; Wildevuur CR; Nieuwenhuis P
    Transplant Proc; 1987 Feb; 19(1 Pt 1):374. PubMed ID: 3274787
    [No Abstract]   [Full Text] [Related]  

  • 34. The immunogenic privilege of corneal allografts.
    Niederkorn JY; Peeler JS; Ross J; Callanan D
    Reg Immunol; 1989; 2(2):117-24. PubMed ID: 2701814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The significance of gender incompatibility in donors and recipients and the role of minor histocompatibility antigens in corneal transplantation].
    Hasková Z; Filipec M; Holán V
    Cesk Slov Oftalmol; 1997 May; 53(2):128-35. PubMed ID: 9296861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic control of rat heart allograft rejection: effect of different MHC and non-MHC incompatibilities.
    Klempnauer J; Steiniger B; Lück R; Günther E
    Immunogenetics; 1989; 30(2):81-8. PubMed ID: 2668160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Ia positive cells in immunologic reaction in transplantation].
    Ochiai T; Suzuki T; Nagata M; Nakajima K; Asano T; Sato H
    Nihon Rinsho; 1985 Jan; 43(1):109-13. PubMed ID: 3157810
    [No Abstract]   [Full Text] [Related]  

  • 38. Is a corneal transplantation immunologically privileged from graft rejection?
    Katami M
    Ann Acad Med Singap; 1991 Jul; 20(4):433-8. PubMed ID: 1799253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of pretransplant sensitization on the survival of corneal allografts.
    D'Amaro J; Volker-Dieben HJ; Kruit PJ; de Lange P; Schipper R
    Transplant Proc; 1991 Feb; 23(1 Pt 1):368-72. PubMed ID: 1990555
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of class I and class II MHC antigens in the rejection of vascularized heart allografts in mice.
    Stepkowski SM; Raza-Ahmad A; Duncan WR
    Transplantation; 1987 Dec; 44(6):753-9. PubMed ID: 3321584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.